Startup Spotlight

PentaBind, a biotech start-up from London, aims to drug the undruggable, targeting diseases that have long been considered beyond the reach of conventional drug discovery methods. Recognising that only 15% of the human proteome has been effectively targeted by existing drugs [2], they are pioneering a novel therapeutic approach that combines the high specificity of aptamers with the power of artificial intelligence (AI).

December 13, 2024

In the quest to revolutionise cancer diagnosis, BioMavericks emerged amidst the COVID-19 crisis, recognizing a crucial gap in advanced sequencing methods for cancer detection. Their ground-breaking in vitro diagnostic tool, fuelled by proprietary biomarkers, with a sensitivity and specificity of over 97% promises exceptional accuracy in detecting prevalent cancers.

December 13, 2024

Anticoagulants are an essential class of medications that are primarily used to prevent thrombotic events in individuals classified as at high risk of blood clot formation. Several risk factors can increase an individual’s risk of developing a blood clot, including a previous history of blood clots (venous thromboembolism), a previous history of myocardial infarction or stroke, cardiac valve replacement, genetic clotting disorders and comorbidities such as atrial fibrillation.

Matthew McCann

December 13, 2024

Beta Bugs are working on developing and distributing new breeds of Black Soldier Fly (BSF) to farmers. BSF is a key circular source of protein for poultry, aquaculture and livestock; the larvae can be fed on organic waste thus converting it to protein for animal consumption. Beta Bugs are looking to become the genetics partner to the BSF industry – starting with their flagship breed HiPer-Fly®️. Specific traits have been selected for, resulting in increased larval size, shorter development time and greater egg production and hatchability.

December 13, 2024

Phase Biolabs is a seed startup that is striving to reduce both CO2 emissions and our petrochemical dependency, by generating sustainable ingredients for industrial and consumer products directly from CO2.

Molly Steadman

December 13, 2024

A biotech company that created a way to create remote-controlled cells to repair damaged tissue using nanotechnology secures £200k investment.

December 13, 2024